Lavender (Lavandula stoechas L.) essential oils attenuate hyperglycemia and protect against oxidative stress in alloxan-induced diabetic rats

Lipids in Health and Disease

Mohsen Sakly¹  Najoua Gharbi¹  Abdelaziz Souli³  Kais Rtibi³  Slimen Selmi²  Hichem Sebai³ 

[1] Laboratoire de Physiologie Intégrée, Faculté des Sciences de Bizerte, 7021 Zarzouna, Tunisia;Département des Sciences de la Vie, Laboratore de Physiologie Animale, Faculté des Sciences de Tunis, Tunis 1060, Tunisia;Laboratoire de Nutrition et Physiologie Animale - Institut Supérieur de Biotechnologie de Béja, Avenue Habib Bourguiba - B.P., 382-9000 Béja, Tunisia

关键词: Antidiabetic;    Antioxidant;    Essential oils;    Rat;    Alloxan;    Lavandula Stoechas;   

Others  :  828999
DOI  :  10.1186/1476-511X-12-189

 received in 2013-08-07, accepted in 2013-12-21,  发布年份 2013

【 摘 要 】

Background

The present study described the phytochemical profile of Lavandula stoechas essential oils, collected in the area of Ain-Draham (North-West of Tunisia), as well as their protective effects against alloxan-induced diabetes and oxidative stress in rat.

Methods

Essential oils samples were obtained from the aerial parts of the plant by hydrodistillation and analyzed by GC–MS. Rats were divided into four groups: Healthy Control (HC); Diabetic Control (DC); Healthy + Essential Oils (H + EO) and Diabetic + Essential Oils (D + EO).

Antidiabetic and antioxidant activities were evaluated after subacute intraperitoneally injection of Lavandula stoechas essential oils (50 mg/kg b.w., i.p.) to rats during 15 days.

Results

The principal compounds detected are: D-Fenchone (29.28%), α-pinene (23.18%), Camphor (15.97%), Camphene (7.83%), Eucapur (3.29%), Limonene, (2.71%) Linalool, (2.01%) Endobornyl Acetate (1.03%). The essential oils also contained smaller percentages of Tricyclene, Cymene, Delta-Cadinene, Selina-3,7(11)-diene. Furthermore, we found that Lavandula stoechas essential oils significantly protected against the increase of blood glucose as well as the decrease of antioxidant enzyme activities induced by aloxan treatment. Subacute essential oils treatment induced a decrease of lipoperoxidation as well as an increase of antioxidant enzyme activities.

Conclusions

These findings suggested that lavandula stoechas essential oils protected against diabetes and oxidative stress induced by alloxan treatment. These effects are in partly due to its potent antioxidant properties.

【 授权许可】

   
2013 Sebai et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

【 参考文献 】

• [1]Walker C, Reamy BV: Diets for cardiovascular disease prevention: what is the evidence? Am Fam Physician 2009, 79:571-588.
• [2]Martinez-Gonzalez MA, Bes-Rastrollo M, Serra-Majem L, Lairon D, Estruch R, Trichopoulou A: Mediterranean food pattern and the primary prevention of chronic disease: recent developments. Nutr Rev 2009, 67(Suppl 1):111-116.
• [3]Austin MA, Hokanson JE, Brunzell JD: Characterization of low density lipoprotein subclasses: methodologic approaches and clinical relevance. Curr Opin Lipidol 1994, 5:395-403.
• [4]Liao L, Starzyk RM, Granger DN: Molecular determinants of oxidized low-density lipoprotein-induced leukocyte adhesion and microvascular dysfunction. Arterioscler Thromb Vasc Biol 1997, 17:437-444.
• [5]Halliwell B: Free radicals, antioxidants and human diseases; curiosity, cause, or consequence. Lancet 1994, 334:721-724.
• [6]Aviram M: Review of human studies on oxidative damage and antioxidant protection related to cardiovascular diseases. Free Radical Res 2000, 33:85-97.
• [7]Wei JY: Age and the cardiovascular system. N Engl J Med 1992, 327:1735-1739.
• [8]Hertog MG, Feskens EJ, Hollman PC, Katan MB, Kromhout D: Dietary antioxidant Flavonoids and risk of coronary heart disease: the Zutphen Elderly Study. Lancet 1993, 342:1007-1011.
• [9]Huxley RR, Neil HA: The relation between dietary flavonol intake and coronary heart disease mortality: a metaanalysis of prospective cohort studies. Eur J Clan Nutr 2003, 57:904-908.
• [10]Sesso HD, Gaziano JM, Liu S, Buring JE: Flavonoid intake and the risk of cardiovascular disease in women. Am J Clin Nutr 2003, 77:1400-1408.
• [11]Fuhrman B, Aviram M: Flavonoids protect LDL from oxidation and attenuate atherosclerosis. Curr Opin Lipidol 2001, 12:41-48.
• [12]Gomez MJ, Jimenez J, Risco S, Zarzuelo A: Hypoglycaemic activity in various species of the genus Lavandula. Pharmazie 1987, 42:706-707.
• [13]Gilani AH, Aziz N, Khan MA, Shaheen F, Jabeen Q, Siddiqui BS, Herzig JW: Ethnopharmacological evaluation of the anticonvulsant, sedative and antispasmodic activities of Lavandula stoechas L. J Ethnopharmacol 2000, 71:161-167.
• [14]Cavanagh HMA, Wilkinson JM: Biological activities of lavender essential oil. Phytother Res 2002, 16:301-308.
• [15]Lis-Balchin M, Deans SG: Bioactivity of selected plant essential oils against Listeria monocytogenes. J Appl Microbiol 1997, 82:759-762.
• [16]Lis-Balchin M, Deans SG, Eagles ham E: Relationship between bioactivity and chemical composition of commercial essential oils. Flavour Frag J 1998, 13:98-104.
• [17]El-Hilaly J, Hmammouchi M, Lyoussi B: Ethnobotanical studies and economic evaluation of medicinal plants in Taounate province (Northern Morocco). J Ethnopharmacol 2003, 86:149-158.
• [18]Lawless J: The Encyclopaedia of Essential Oils. Melbourne, Australia: Element; 1992.
• [19]Gattefosse RM: Gattefosse’s Aromatherapy. Essex, England: CW Daniel; 1993.
• [20]Nadkarni KM: Indian materia medica p. 730 (3rd ed.). Bombay: Popular Prakashan; 1982.
• [21]Usmanghani K, Saeed A, Alam MT: Indusyunic medicine. Karachi: University of Karachi Press; 1997:273.
• [22]Benabdelkader T, Zitouni A, Guitton Y, Jullien F, Maitre D, Casabianca H, Legendre L, Kameli A: Essential oils from wild populations of Algerian Lavandula stoechas L.: composition, chemical variability, and in vitro biological properties. Chem Biodivers 2011, 8:937-953.
• [23]Grzegorczyk I, Matkowski A, Wysokinska H: Antioxidant activity of extracts from in vitro cultures of Salvia officinalis L. Food Chem 2007, 104:536-541.
• [24]Liu J, Yu Y, Fan YZ, Chang H, Liu HM, Cui Y, Chen Q, Wang R: Cardiovascular effects of endomorphins in alloxan-induced diabetic rats. Peptides 2005, 26:607-614.
• [25]Begue JA, Aust SD: Microsomal lipid peroxidation. Meth Enzymol 1978, 52:302-310.
• [26]Ellman GL: Tissue sulfhydryl groups. Arch Biochem Biophys 1959, 82:70-77.
• [27]Misra HP, Fridovich I: The role of superoxide anion in the autoxidation of epinephrine and simple assay for superoxide dismutase. J Biol 1972, 247:3170-3175.
• [28]Azhar S, Cao L, Reaven E: Alteration of the adrenal antioxidant defense system during aging in rats. J Clin Invest 1995, 96:1414-1424.
• [29]Aebi H: Catalase in vitro. Meth Enzymol 1984, 105:121-126.
• [30]Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principal of protein-dye binding. Anal Biochem 1976, 72:248-254.
• [31]Lott JA, Stang JM: Serum enzymes and isoenzymes in the diagnosis and differential diagnosis of myocardial ischemia and necrosis. Clin Chem 1980, 26:1241-50.
• [32]Dob T, Dahmane D, Tayeb B, Chelghoum C: Chemical composition of the essential oil of Lavandula dentata L. From Algeria. The Int J Aromath 2005, 15:110-114.
• [33]Pascual TJD, Caballero E, Caballero C, Machin G: Constituents of the essential oil of Lavandula latifolia. Phytochem 1983, 22:1033-1034.
• [34]Perry NB, Anderson RE, Brennan NJ, Douglas MH, Heane AJ, Mc Grimpsey JA, Smallfield BM: Essential oil from Dalmatian sage (Salvia officinalis L.), variations among individuals, plant parts, seasons and sites. J Agric Food Chem 1999, 47:2048-2054.
• [35]Pascual TJD, Ovejero J, Anaya J, Caballero E, Hernandez JM: Chemical composition of the Spanish spike oil. PlantaMedica 1989, 55:398-399.
• [36]Barazandeh MM: Essential oil composition of Lavandula latifolia Medik from Iran. J Essent Oil Res 2002, 14:103-104.
• [37]Nogueira JMF, Romano A: Essential oils from micropropagated plants of Lavandula viridis. Phytochem Anal 2002, 13:4-7.
• [38]Szkudelski T: The mechanism of alloxan and streptozotocin action in b-cells of the rat pancreas. Physiol Res 2001, 50:536-546.
• [39]Cam CM, Cros HG, Serrano JJ, Lazaro R, McNeill HJ: In vivo antidiabetic actions of naglivan, an organic vanadyl compound in streptozotocin-induced diabetes. Diab Res Clin Pract 1993, 20:111-121.
• [40]Pari L, Saravanan G: Antidiabetic effect of cogent db, a herbal drug in alloxan induced diabetes. Comp Biochem Physiol 2002, 131:19-25.
• [41]Martinez JA, Milagro FI: Effects of the oral administration of a β3-adrenergic agonist on lipid metabolism in alloxan-diabetic rats. J Pharm Pharmacol 2000, 52:851-856.
• [42]Pushparaj NP, Tan HKB, Tan HC: The mechanism of hypoglycemic action of the semi purified fractions of Averrhoa bilimbi in streptozotocin diabetic rats. Life Sci 2001, 70:535-547.
• [43]Laakso M: Epidemiology of diabetic dislipidemia. Diab Rev 1995, 3:408-422.
• [44]Burtis CA, Ashwood ER: Enzymes, Teitz fundamentals of clinical chemistry. 4th edition. Philadelphia, USA: NB Saunders Company; 1996:312-335.
• [45]Almdal TP, Vilstrup H: Strict insulin treatment normalizes the organic nitrogen contents and the capacity of urea-N synthesis in experimental diabetes in rats. Diabetologica 1988, 31:114-118.
• [46]Whitehead MW, Hawkes ND, Hainsworth I, Kingham JGC: A prospective study of the causes of notably raised aspartate transaminase of liver origin. Gut 1999, 45:129-133.
• [47]Larcan A, Lambert H, Laprevote-Heully MC, Delorme N: Light and electron microscopic study of hepatic lesions in the course of hyperlactatemia in diabetic patients. Diab Metab 1979, 5:103-112.
• [48]Navarro CM, Montilla PM, Martin A, Jimenez J, Utrilla PM: Free radicals scavenger and antihepatotoxic activity of Rosmarinus. Plant Med 1993, 59:312-314.
• [49]Estornell E, Barber T, Cabo J: Improved nitrogen metabolism in rats fed on lipid-rich liquid diets. Br J Nutr 1994, 71:361-373.
• [50]Del Rio D, Stewart AJ, Pellegrini N: A review of recent studies on malondialdehyde as toxic molecule and biological marker of oxidative stress. Nutr Metab Cardiovasc Dis 2005, 15:316-328.
• [51]Al-Azzawie H, Alhamdani MSS: Hypoglycaemic and antioxidant effect of oleuropein in alloxan-diabetic rabbits. Life Sci 2006, 78:1371-1377.
• [52]Sepici-Dincel A, Acıkgoz S, Cevik C, Sengelen M, Yes¸ilada E: Effects of in vivo antioxidant enzyme activities of myrtle oil in normoglycaemic and alloxan diabetic rabbits. J Ethnopharmacol 2007, 110:498-503.
• [53]Matosa F, Miguela MG, Duartea J, Venânciob F, Moiteirob C, Correiac AID, Figueiredod AC, Barrosod JG, Pedrod LG: Antioxidant capacity of the essential oils from Lavandula luisieri, L. stoechas subsp. lusitanica, L. stoechas subsp. lusitanica x L. luisieri and L. viridis grown in Algarve (Portugal). J Essent Oil Res 2009, 21:327-336.
• [54]Kumazawa S, Taniguchi M, Suzuki Y, Shimura M, Kwon MS, Nakayama T: Antioxidant activity of polyphenols in carob pods. J Agric Food Chem 2002, 50:373-377.
• [55]Kamalakannan N, Prince PSM: Antihyperglycaemic and antioxidant effect of rutin, a polyphenolic flavonoid, in streptozotocin-induced diabetic wistar rats. Basic Clin Pharmacol Toxico 2006, 98:97-103.
• [56]Memis o’gullar R, Bakan E: Levels of ceruloplasmin, transferin, and lipid peroxidation in the serum of patients with type 2 diabetes mellitus. J Diabetes Complications 2004, 18:193-197.
• [57]Arulselvan P, Subramanian SP: Beneficial effects of Murraya koenigii leaves on antioxidant defense system and ultra structural changes of pancreatic-cells in experimental diabetes in rats. Chem Biol Interact 2007, 165:155-164.